文献速递胸部CT

基于CT的影像组学特征预测重症COVID-19肺炎:开发与多中心验证

Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia.
PubMed 文献 · Eur Radiol · 2021-03-30

基于CT的影像组学模型在训练、验证和测试队列中AUC分别为0.9、0.878和0.842,优于临床因素联合定量CT模型,决策曲线分析显示临床有用性更佳。

要点

  • 影像组学特征为重症COVID-19的独立预测因子。
  • CT影像组学模型预测重症的AUC在测试队列为0.842。
  • 影像组学模型 discrimination 优于临床因素联合定量CT模型。

核心结论

  • 基于CT的影像组学特征对重症COVID-19显示出良好的预测效能,可能辅助临床制定精准治疗方案。

研究设计与样本

  • 从胸部CT图像提取影像组学特征,采用LASSO逻辑回归(5折交叉验证)构建影像组学特征。
  • 基于定量CT特征、影像组学特征、临床因素及其组合建立不同逻辑回归模型,评估列线图的校准、区分度和临床有用性。

诊断标准与关键数值

  • CT影像组学模型在训练队列AUC 0.9(95%CI 0.843-0.942),验证队列AUC 0.878(95%CI 0.796-0.958),测试队列AUC 0.842(95%CI 0.761-0.922)。
  • 临床因素联合定量CT模型在训练队列AUC 0.781(95%CI 0.708-0.843),验证队列AUC 0.814(95%CI 0.703-0.897),测试队列AUC 0.696(95%CI 0.581-0.796)。

临床应用与阅片要点

  • 影像组学模型可作为独立预测工具,辅助识别可能发展为重症的COVID-19患者。
  • 决策曲线分析显示影像组学模型临床有用性优于临床因素模型和定量CT模型。

局限性

  • 回顾性研究设计。
  • 仅纳入两家机构,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia.

MATERIALS AND METHODS: Three hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and testing cohorts. Radiomics features were extracted from chest CT images. Radiomics signature was constructed based on reproducible features using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm with 5-fold cross-validation. Logistic regression modeling was employed to build different models based on quantitative CT features, radiomics signature, clinical factors, and/or the former combined features. Nomogram performance for severe COVID-19 prediction was assessed with respect to calibration, discrimination, and clinical usefulness.

RESULTS: Sixteen selected features were used to build the radiomics signature. The CT-based radiomics model showed good calibration and discrimination in the training cohort (AUC, 0.9; 95% CI, 0.843-0.942), the validation cohort (AUC, 0.878; 95% CI, 0.796-0.958), and the testing cohort (AUC, 0.842; 95% CI, 0.761-0.922). The CT-based radiomics model showed better discrimination capability (all p < 0.05) compared with the clinical factors joint quantitative CT model (AUC, 0.781; 95% CI, 0.708-0.843) in the training cohort, the validation cohort (AUC, 0.814; 95% CI, 0.703-0.897), and the testing cohort (AUC, 0.696; 95% CI, 0.581-0.796). Decision curve analysis demonstrated that in terms of clinical usefulness, the radiomics model outperformed the clinical factors model and quantitative CT model alone.

CONCLUSIONS: The CT-based radiomics signature shows favorable predictive efficacy for severe COVID-19, which might assist clinicians in tailoring precise therapy.

KEY POINTS: • Radiomics can be applied in CT images of COVID-19 and radiomics signature was an independent predictor of severe COVID-19. • CT-based radiomics model can predict severe COVID-19 with satisfactory accuracy compared with subjective CT findings and clinical factors. • Radiomics nomogram integrated with the radiomics signature, subjective CT findings, and clinical factors can achieve better severity prediction with improved diagnostic performance.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li L, Wang L, Zeng F, et al. Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia. Eur Radiol. 2021. PMID: 33786655. doi:10.1007/s00330-021-07727-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。